|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows Used in Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Net accretion of discounts/premiums on debt securities | |||||
| Share-based compensation | |||||
| Gain on sale of joint venture | |||||
| Loss on investment in joint venture | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses, operating right-of-use assets and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and operating lease liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Cash Flows Provided by Investing Activities: | |||||
| Purchases of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Purchase of property and equipment | |||||
| Proceeds from sale of common stock received from sale of joint venture | |||||
| Investment in joint venture | |||||
| Net cash provided by investing activities | |||||
| Cash Flows Provided by Financing Activities: | |||||
| Proceeds from the issuance of common stock and pre-funded warrants upon the completion of the follow-on offering, net of underwriting discounts and commissions of $3,289 | |||||
| Proceeds from the issuance of common stock from a securities purchase agreement | |||||
| Proceeds from the issuance of common stock under the stock purchase plan | |||||
| Proceeds from the issuance of common stock from exercise of stock options | |||||
| Payments of offering costs | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents—beginning of year | |||||
| Cash and cash equivalents—end of year | |||||
| Offering costs in accounts payable and accrued expenses | |||||
Loading...